Exposure to vitamin k antagonists and kidney function decline in patients with atrial fibrillation and chronic kidney disease

BACKGROUND: Exposure to vitamin K antagonists (VKA) has been suggested to accelerate progression of chronic kidney disease (CKD) but robust clinical data are currently lacking. METHODS: We retrospectively evaluated the impact of VKA exposure on kidney function in patients with atrial fibrillation (A...

Descripción completa

Detalles Bibliográficos
Autores principales: Posch, Florian, Ay, Cihan, Stöger, Herbert, Kreutz, Reinhold, Beyer‐Westendorf, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles: Thrombosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462762/
https://www.ncbi.nlm.nih.gov/pubmed/31011705
http://dx.doi.org/10.1002/rth2.12189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462762/
https://www.ncbi.nlm.nih.gov/pubmed/31011705
http://dx.doi.org/10.1002/rth2.12189

Ejemplares similares